EMBL sells ViraTherapeutics to trade for €210m
Heidelberg-based life sciences VC firm EMBL Ventures has sold its stake in biotechnology company ViraTherapeutics to pharmaceuticals business Boehringer Ingelheim in a transaction valuing the business at €210m.
More on Exits
BluGem sells DMC Group to Lion Capital
Sale ends a three-year holding period for BlueGem, which bought the company via its €370m second fund
True rescues portfolio company TyresOnTheDrive
GP previously invested in the tyre e-commerce business, which entered administration in January
EQT sells 20% of IVC to pension funds
Deal reportedly values the company at £2.6bn, affords EQT more time before a future IPO
VCDE, Time for Growth sell Brille24 to Essilor
Time for Growth invested in international expansion and technology over the holding period
Latest News
Idinvest et al. inject €25m in Malt series-B
VCs Serena and Isai re-up, having previously backed the €5m series-A in 2016
Alto Partners acquires Bia
Third investment made by Alto Capital IV, which held a €210m final close in 2018
Ex-HQ Capital CEO moves to Schroders
Based in London and Frankfurt, Wunderlin will report to group chief executive Peter Harrison
Ardian’s Revima completes two bolt-ons
Ardian bought a majority stake in France-based Revima from Argos Wityu last month